Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% of Skechers USA Inc (SKX)’s shares, while financial institutions hold 81.69%.

Harbor Capital Advisors Inc. lowered its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 8.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a

In a report released today, Paul Newsome from Piper Sandler assigned a Hold rating to Travelers Companies (TRV – Research Report), with a price

Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $5.91 which represents a slight increase of $0.15 or 2.60% from the prior close of $5.76. The stock opened at $5.9 and touched a low of $5.

Cigna Group (CI) stock saw a modest uptick, ending the day at $283.99 which represents a slight increase of $3.02 or 1.07% from the prior close of $280.97. The stock opened at $281.09 and touched a low of $279.

Piper Sandler analyst Scott Siefers maintained a Buy rating on Citigroup (C – Research Report) today and set a price target of $83.00. The

Piper Sandler analyst Scott Siefers maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report) today and set a price target of

The Hain Celestial Group (NASDAQ:HAIN – Get Free Report) had its price objective decreased by analysts at Piper Sandler from $8.00 to $7.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock.

In a report released on January 15, Nik Modi from RBC Capital maintained a Buy rating on The Estée Lauder Companies (EL – Research Report),

Barclays analyst Andrew Lazar maintained a Buy rating on Mondelez International (MDLZ – Research Report) today and set a price target of

Marsh & McLennan Companies Inc (MMC) stock saw a decline, ending the day at $212.59 which represents a decrease of $-0.78 or -0.37% from the prior close of $213.37. The stock opened at $214.43 and touched a low of $211.